Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Meyers

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Physical Therapy in Sport : Official Journal of the Association of Chartered Physiotherapists in Sports Medicine|March 8, 2022
The association between lower extremity strength ratios and the history of injury in collegiate athletesEmily Vosburg, Michelle Hinkey, Rachel Meyers, et al.
Physical Therapy in Sport : Official Journal of the Association of Chartered Physiotherapists in Sports Medicine|September 24, 2025
Low energy availability risk and in-season injuries among female adolescent athletes: A prospective cohort study over a school-seasonKatherine L Smulligan, Madison L Brna, Veronica Hogg-Cornejo, et al.
Plos One|November 22, 2014
Respiratory syncytial virus human experimental infection model: provenance, production, and sequence of low-passaged memphis-37 challenge virusYoung-In Kim, John P DeVincenzo, Bart G Jones, et al.
The Journal of Infectious Diseases|May 16, 2015
Effect of Preexisting Serum and Mucosal Antibody on Experimental Respiratory Syncytial Virus (RSV) Challenge and Infection of AdultsBindiya Bagga, Jeffrey E Cehelsky, Akshay Vaishnaw, et al.
Molecular Therapy. Nucleic Acids|January 25, 2013
Formulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 ExpressionRobert F Place, Ji Wang, Emily J Noonan, et al.
American Heart Journal|June 29, 2024
Decreased postpartum exercise capacity after a diagnosis of pre-eclampsia: Implications for CVD risk predictionKathryn J Lindley, Claire Barker, Zainab Mahmoud, et al.
Silence|August 25, 2010
In vivo quantification of formulated and chemically modified small interfering RNA by heating-in-Triton quantitative reverse transcription polymerase chain reaction (HIT qRT-PCR)Yosef Landesman, Nenad Svrzikapa, Armand Cognetta, et al.
Antiviral Research|February 5, 2008
Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)John DeVincenzo, Jeffrey E Cehelsky, Rene Alvarez, et al.
Assay and Drug Development Technologies|April 20, 2004
Development of a high-throughput assay for two inositol-specific phospholipase Cs using a scintillation proximity formatMichael E Bembenek, Sadhana Jain, Andrea Prack, et al.
Journal of Molecular Biology|August 24, 2024
Single Acetylation-mimetic Mutation in TDP-43 Nuclear Localization Signal Disrupts Importin α1/β SignalingYing-Hui Ko, Ravi K Lokareddy, Steven G Doll, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Physical Therapy in Sport : Official Journal of the Association of Chartered Physiotherapists in Sports Medicine|March 8, 2022
The association between lower extremity strength ratios and the history of injury in collegiate athletesEmily Vosburg, Michelle Hinkey, Rachel Meyers, et al.
Physical Therapy in Sport : Official Journal of the Association of Chartered Physiotherapists in Sports Medicine|September 24, 2025
Low energy availability risk and in-season injuries among female adolescent athletes: A prospective cohort study over a school-seasonKatherine L Smulligan, Madison L Brna, Veronica Hogg-Cornejo, et al.
Plos One|November 22, 2014
Respiratory syncytial virus human experimental infection model: provenance, production, and sequence of low-passaged memphis-37 challenge virusYoung-In Kim, John P DeVincenzo, Bart G Jones, et al.
The Journal of Infectious Diseases|May 16, 2015
Effect of Preexisting Serum and Mucosal Antibody on Experimental Respiratory Syncytial Virus (RSV) Challenge and Infection of AdultsBindiya Bagga, Jeffrey E Cehelsky, Akshay Vaishnaw, et al.
Molecular Therapy. Nucleic Acids|January 25, 2013
Formulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 ExpressionRobert F Place, Ji Wang, Emily J Noonan, et al.
American Heart Journal|June 29, 2024
Decreased postpartum exercise capacity after a diagnosis of pre-eclampsia: Implications for CVD risk predictionKathryn J Lindley, Claire Barker, Zainab Mahmoud, et al.
Silence|August 25, 2010
In vivo quantification of formulated and chemically modified small interfering RNA by heating-in-Triton quantitative reverse transcription polymerase chain reaction (HIT qRT-PCR)Yosef Landesman, Nenad Svrzikapa, Armand Cognetta, et al.
Antiviral Research|February 5, 2008
Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)John DeVincenzo, Jeffrey E Cehelsky, Rene Alvarez, et al.
Assay and Drug Development Technologies|April 20, 2004
Development of a high-throughput assay for two inositol-specific phospholipase Cs using a scintillation proximity formatMichael E Bembenek, Sadhana Jain, Andrea Prack, et al.
Journal of Molecular Biology|August 24, 2024
Single Acetylation-mimetic Mutation in TDP-43 Nuclear Localization Signal Disrupts Importin α1/β SignalingYing-Hui Ko, Ravi K Lokareddy, Steven G Doll, et al.
Pageof 6